Prelude Therapeutics to Participate in Barclays Global Healthcare Conference

Rhea-AI Summary

Prelude Therapeutics Incorporated (Nasdaq: PRLD) will participate in the Barclays Global Healthcare Conference. The CEO and Chief Medical Officer will be part of a fireside chat on March 13, 2024. The event will be live webcasted and archived on the company's website.

WILMINGTON, Del., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays Global Healthcare Conference in Miami, March 12-14, 2024.

On Wednesday, March 13, at 3:05 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat, hosted by Barclays.

A live webcast of the fireside chat can be accessed here and on the Company’s website under Events and Presentations. The recording will be archived and available on the Company’s website for 90 days.

About Prelude Therapeutics
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company’s diverse pipeline is comprised of highly differentiated, potentially best-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways for cancers with selectable underserved patients. Prelude’s pipeline includes three candidates currently in clinical development: an IV administered, potent and highly selective SMARCA2 degrader, PRT3789, a preclinical oral SMARCA2 selective degrader, PRT7732, a potent and highly selective CDK9 inhibitor, PRT2527, and a next generation CDK4/6 inhibitor, PRT3645.

For more information, visit our website and follow us on LinkedIn.

Investor Contact: 
Lindsey Trickett 
Vice President, Investor Relations 
240.543.7970 
ltrickett@preludetx.com  
  
Media Contact: 
Helen Shik  
Shik Communications  
617.510.4373  
Helen@ShikCommunications.com

FAQ

When will Prelude Therapeutics participate in the Barclays Global Healthcare Conference?

Prelude Therapeutics will participate in the Barclays Global Healthcare Conference on March 12-14, 2024.

Who will be part of the fireside chat at the conference?

Kris Vaddi, Ph.D., Chief Executive Officer, and Jane Huang, M.D., President and Chief Medical Officer, will participate in the fireside chat.

Where can the live webcast of the fireside chat be accessed?

The live webcast of the fireside chat can be accessed on the company's website under Events and Presentations.

How long will the recording of the fireside chat be available on the company's website?

The recording of the fireside chat will be archived and available on the company's website for 90 days.